João Pedro Ferreira

Researcher Next ID · RN-024980

Researcher · Medicine

Paris, Portugal

Not currently recruitingFunding unknown

Research interests

Medicine

Heart Failure Treatment and Management

Diabetes Treatment and Management

Cardiovascular Function and Risk Factors

Hormonal Regulation and Hypertension

Hyperglycemia and glycemic control in critically ill and hospitalized patients

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Nature Medicine · 2022 · https://doi.org/10.1038/s41591-021-01659-1
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2107038
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)30748-0
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31824-9
Baseline Characteristics of Patients with Heart Failure with Preserved Ejection Fraction in the EMPEROR-Preserved Trial
European Journal of Heart Failure · 2020 · https://doi.org/10.1002/ejhf.2064

No projects listed.